NCT00536393View on ClinicalTrials.gov

Treatment of Disseminated High Grade Lymphoma

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2000

Study Completion Date

October 31, 2004

Conditions
Lymphoma
Interventions
DRUG

Doxorubicin

DRUG

Doxorubicin pegylated

Trial Locations (1)

72015

Clinique Victor Hugo, Le Mans

All Listed Sponsors
lead

French Innovative Leukemia Organisation

OTHER

NCT00536393 - Treatment of Disseminated High Grade Lymphoma | Biotech Hunter | Biotech Hunter